Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
beta tricalcium phosphate + hydroxyapatite
- Development stage
- Unknown
- Lead developer
- The Ohio State University
- Administration
- Topical
01
Overview
Beta tricalcium phosphate + hydroxyapatite (βTCP/HA) is a biphasic calcium phosphate (BCP) ceramic used as a bone substitute material in periodontal regenerative surgery. It consists of a mixture of hydroxyapatite (HA), which provides a stable, long-term scaffold for bone growth due to its low resorption rate, and beta-tricalcium phosphate (β-TCP), which is more soluble and promotes faster bone turnover. In a clinical trial led by Ohio State University, this material was evaluated for its efficacy in treating mandibular class II furcation defects in patients with chronic periodontitis, both as a standalone filling material and in combination with Enamel Matrix Derivative (EMD). The treatment aims to achieve clinical attachment gain and reduce probing pocket depths by providing a framework for new bone formation.
- Other names
- BoneBone graftBiphasic calcium phosphateBCPβ-TCP/HA
Beyond the preview
Go deeper on beta tricalcium phosphate + hydroxyapatite.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on beta tricalcium phosphate + hydroxyapatite.